XML 95 R74.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDERS' EQUITY (Details 3) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Y
Dec. 31, 2010
Dec. 31, 2009
Common Stock Options, Quantity      
Exercised (in shares) (364,324) (2,728,000) (2,072,533)
Intrinsic value of common stock options, SAR and equity based incentive awards exercised during the period      
Stock-based compensation expense recognized $ 18,318 $ 34,005 $ 47,607
Compensation cost related to unvested granted awards not yet recognized 11,172    
Weighted average period of recognition of unrecognized compensation cost related to nonvested awards (in years) 3.03    
Common stock options
     
Common Stock Options, Quantity      
Outstanding at the beginning of the period (in shares) 7,426,499    
Granted (in shares) 945,625    
Modified December 15, 2011 (in shares) (211,283)    
Modified December 15, 2011 (in shares) 211,283    
Exercised (in shares) (364,326)    
Forfeited (in shares) (1,436,488)    
Expired (in shares) (130,000)    
Outstanding at the end of the period (in shares) 6,441,310 7,426,499  
Common Stock Options, Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 16.78    
Granted (in dollars per share) $ 18.08    
Modified December 15, 2011 (in dollars per share) $ 5.49    
Exercised (in dollars per share) $ 14.69    
Forfeited (in dollars per share) $ 12.27    
Expired (in dollars per share) $ 23.42    
Outstanding at the end of the period (in dollars per share) $ 17.96 $ 16.78  
Nonvested Common Stock Options, Quantity      
Nonvested Common Stock Options at the beginning of the period (in shares) 4,204,468    
Granted (in shares) 945,625    
Modified December 15, 2011 (in shares) (211,283)    
Modified December 15, 2011 (in shares) 211,283    
Vested (in shares) (2,356,414)    
Forfeited (in shares) (1,436,488)    
Nonvested Common Stock Options at the end of the period (in shares) 1,357,191 4,204,468  
Nonvested Common Stock Options, Weighted average grant-date fair value      
Nonvested options at the beginning of the period (in dollars per share) $ 10.97    
Granted (in dollars per share) $ 7.88    
Modified December 15, 2011 (in dollars per share) $ 11.90    
Modified December 15, 2011 (in dollars per share) $ 3.34    
Vested (in dollars per share) $ 10.15    
Forfeited (in dollars per share) $ 10.10    
Nonvested options at the end of the period (in dollars per share) $ 10.13 $ 10.97  
Vested Common stock options      
Vested Common Stock Options, Quantity (in shares) 5,084,119    
Vested Common Stock Options, Weighted Average Exercise Price (in dollars per share) $ 18.10    
Vested Common Stock Options, Weighted Average Remaining Contractual Term (in years) 6.9    
Intrinsic value of common stock options and equity based incentive awards outstanding and exercisable      
Intrinsic value of options outstanding/exercisable 2,757    
Intrinsic value of common stock options, SAR and equity based incentive awards exercised during the period      
Total intrinsic value of options exercised 2,575 11,651  
Equity-based incentive awards
     
Equity-based incentive awards, Quantity      
Outstanding at the beginning of the period (in shares) 3,192,483    
Granted (in shares) 512,500    
Exercised (in shares) (213,406)    
Forfeited (in shares) (649,688)    
Expired (in shares) (3,750)    
Outstanding at the end of the period (in shares) 2,838,139 3,192,483  
Equity-based incentive awards, Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 14.00    
Granted (in dollars per share) $ 14.00    
Exercised (in dollars per share) $ 14.00    
Forfeited (in dollars per share) $ 14.00    
Expired (in dollars per share) $ 14.00    
Outstanding at the end of the period (in dollars per share) $ 14.00 $ 14.00  
Nonvested Equity-based incentive awards, Quantity      
Outstanding at the beginning of the period (in shares) 2,276,667    
Granted (in shares) 512,500    
Vested (in shares) (1,196,041)    
Forfeited (in shares) (649,688)    
Outstanding at the end of the period (in shares) 943,438 2,276,667  
Nonvested Equity-based incentive awards, Weighted average grant-date fair value      
Outstanding at the beginning of the period (in dollars per share) $ 2.80    
Granted (in dollars per share) $ 2.80    
Vested (in dollars per share) $ 2.80    
Forfeited (in dollars per share) $ 2.80    
Outstanding at the end of the period (in dollars per share) $ 2.80 $ 2.80  
Vested Equity-based incentive awards      
Vested Equity-based incentive awards, Quantity (in shares) 1,894,701    
Vested Equity-based incentive awards, Weighted Average Exercise Price (in dollars per share) $ 14.00    
Vested Equity-based incentive awards, Weighted Average Remaining Contractual Term (in years) 7.8    
Intrinsic value of common stock options and equity based incentive awards outstanding and exercisable      
Intrinsic value of equity-based incentive awards outstanding/exercisable 2,757    
Intrinsic value of common stock options, SAR and equity based incentive awards exercised during the period      
Total intrinsic value of equity instruments other than options 598 857  
Expected option life (in years) 4.5    
Stock appreciation right (SAR)
     
Intrinsic value of common stock options, SAR and equity based incentive awards exercised during the period      
Total intrinsic value of equity instruments other than options     $ 45,347